EVIDENCE FOR CELL-SPECIFIC DIFFERENCES IN TRANSFORMATION BY N-RAS, H-RAS AND K-RAS

被引:0
|
作者
MAHER, J
BAKER, DA
MANNING, M
DIBB, NJ
ROBERTS, IAG
机构
[1] HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT HAEMATOL, LONDON W12 0NN, ENGLAND
[2] HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT OBSTET & GYNAECOL, LONDON W12 0NN, ENGLAND
关键词
N-RAS; H-RAS; K-RAS; TRANSFORMATION;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although Ras plays a fundamental role in cellular proliferation, differentiation and transformation, clear functional differences between the three major Ras proteins (N-, H- and K-Ras) have not as yet been demonstrated. In this study, chimeric constructs were used to compare directly transformation by N-, H- and E-vas oncogenes. In Rat-2 and MH3T3 fibroblasts, transformation assays (anchorage independence, focus-formation and growth in 1% FCS) showed that H-12-Ras was more transforming than N-12-Ras or K-12-Ras. By contrast, in the human multipotent haemopoietic cell line, TF-1, N-12-Ras exhibited greater biological activity. Northern blotting and protein analyses indicated that these findings were not the result of differences in expression or stability of p21Ras. Using further H-ras/N-ras chimeric constructs, we found that the greater transforming activity of H-12-Ras in fibroblasts was not due to the hypervariable-CAAX region, but rather to unique sequences between amino acids 84 and 143. These data demonstrate cell specific differences in the intrinsic transforming potential of N-ras, H-ras and K-ras oncogenes.
引用
收藏
页码:1639 / 1647
页数:9
相关论文
共 50 条
  • [1] N-RAS, H-RAS, AND K-RAS - A DIFFERENCE IN TRANSFORMING POTENTIAL
    MAHER, J
    BAKER, DA
    DIBB, NJ
    ROBERTS, IAG
    [J]. BLOOD, 1994, 84 (10) : A295 - A295
  • [2] H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers
    Przybojewska, B
    Jagiello, A
    Jalmuzna, P
    [J]. CANCER GENETICS AND CYTOGENETICS, 2000, 121 (01) : 73 - 77
  • [3] ANALYSIS OF H-RAS, K-RAS AND N-RAS GENES FOR EXPRESSION, MUTATION AND AMPLIFICATION IN LARYNGEAL TUMORS
    KIARIS, H
    SPANDIDOS, DA
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (01) : 75 - 80
  • [4] Analysis of K-ras, N-ras, H-ras, and p53 in lung neuroendocrine neoplasms
    Couce, ME
    Bautista, D
    Costa, J
    Carter, D
    [J]. DIAGNOSTIC MOLECULAR PATHOLOGY, 1999, 8 (02) : 71 - 79
  • [5] IMMUNOHISTOCHEMICAL DETECTION OF THE H-RAS, K-RAS, AND N-RAS ONCOGENES IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    MCDONALD, JS
    JONES, H
    PAVELIC, ZP
    PAVELIC, LJ
    STAMBROOK, PJ
    GLUCKMAN, JL
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1994, 23 (08) : 342 - 346
  • [6] Differences in the Regulation of K-Ras and H-Ras Isoforms by Monoubiquitination
    Baker, Rachael
    Wilkerson, Emily M.
    Sumita, Kazutaka
    Isom, Daniel G.
    Sasaki, Atsuo T.
    Dohlman, Henrik G.
    Campbell, Sharon L.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (52) : 36856 - 36862
  • [7] Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients
    Malgorzata Banys-Paluchowski
    Karin Milde-Langosch
    Tanja Fehm
    Isabell Witzel
    Leticia Oliveira-Ferrer
    Barbara Schmalfeldt
    Volkmar Müller
    [J]. Breast Cancer Research and Treatment, 2020, 179 : 403 - 414
  • [8] Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors
    Vageli, D
    Kiaris, H
    Delakas, D
    Anezinis, P
    Cranidis, A
    Spandidos, DA
    [J]. CANCER LETTERS, 1996, 107 (02) : 241 - 247
  • [9] The K-Ras, N-Ras, and H-Ras Isoforms: Unique Conformational Preferences and Implications for Targeting Oncogenic Mutants
    Parker, Jillian A.
    Mattos, Carla
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (08):
  • [10] Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients
    Banys-Paluchowski, Malgorzata
    Milde-Langosch, Karin
    Fehm, Tanja
    Witzel, Isabell
    Oliveira-Ferrer, Leticia
    Schmalfeldt, Barbara
    Mueller, Volkmar
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (02) : 403 - 414